Anti-EBV/HHV-4 LMP1/BNLF1 Antibody (A4)

Catalog No.

RVV07008

Species reactivity

Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4)

Host species

Human

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

Latent membrane protein 1, LMP-1, Protein p63, Protein p25, LMP1, BNLF1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03230

Applications

ELISA, IP

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

A4

Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567

EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma., PMID:39695702

Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy., PMID:39211169

A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations., PMID:38995124

Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma., PMID:38276183

Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830

CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy., PMID:38211650

LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells., PMID:38169736

Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus., PMID:38146370

Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells., PMID:37876925

Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto's thyroiditis., PMID:37858193

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein., PMID:37512884

Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma., PMID:37508413

Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas., PMID:37426645

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma., PMID:37373272

Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes., PMID:37116366

Epstein-Barr Virus-Positive Leiomyosarcoma in Immunocompetent Patients., PMID:36951222

Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus., PMID:36782252

Association of human papillomavirus and Epstein-Barr virus with squamous cell carcinoma of upper aerodigestive tract., PMID:36683943

PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis., PMID:36326378

Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1)., PMID:35478129

Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis., PMID:34790199

Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response., PMID:34728343

Uncovering early events in primary Epstein-Barr virus infection using a rabbit model., PMID:34707156

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases., PMID:34691042

Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations., PMID:34612761

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma., PMID:34546798

Updating targets for natural killer/T-cell lymphoma immunotherapy., PMID:33628584

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity., PMID:33613527

Selection of new immunotherapy targets for NK/T cell lymphoma., PMID:33312349

A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma., PMID:33067267

Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection., PMID:32343232

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis., PMID:32333154

[Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer]., PMID:31851189

CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo., PMID:31807014

Construction of Epstein-Bar virus cocktail peptide fused with Fcγ of IgG: as a potential delivery system for vaccine development., PMID:31739735

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma., PMID:31618442

Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection., PMID:31360295

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma., PMID:31063269

Fibronectin promotes nasopharyngeal cancer cell motility and proliferation., PMID:30551431

Epstein Barr Virus in Patients with Nephropathy Associated with Systemic Lupus Erythematous, Pilot Study in Egyptian Patients., PMID:30242993

Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1., PMID:30137504

Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas., PMID:29946193

Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma., PMID:29761078

The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China., PMID:29606628

The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus., PMID:29497417

Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus., PMID:29338588

The potential of currently unavailable herpes virus vaccines., PMID:29313728

Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar., PMID:29228016

Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1., PMID:29063322

Document Download

Anti-EBV/HHV-4 LMP1/BNLF1 Antibody (A4).pdf